Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Biomed Anal ; 248: 116263, 2024 Sep 15.
Article in English | MEDLINE | ID: mdl-38852296

ABSTRACT

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. HCC is often diagnosed late because patients with early-stage cancer have no apparent symptoms. Therefore, it is desirable to find a reliable method for an early diagnosis based on the detection of metabolites - biomarkers, that can be detected in the early stages of the disease. Untargeted metabolomics is often used as a tool to find a suitable biomarker for several diseases. In this work, untargeted metabolomics was performed on blood plasma samples of HCC patients and compared with healthy individuals and patients with liver cirrhosis. A combination of liquid chromatography and high-resolution mass spectrometry was used as an analytical method. More than a thousand peaks were detected in the blood plasma samples, from which mainly amino acids, carboxylic acids, lipids, and their derivatives were evaluated as potential biomarkers. The data obtained were statistically processed using the analysis of variance, correlation analysis, and principal component analysis.


Subject(s)
Biomarkers, Tumor , Carcinoma, Hepatocellular , Liver Neoplasms , Metabolomics , Humans , Carcinoma, Hepatocellular/blood , Liver Neoplasms/blood , Metabolomics/methods , Male , Biomarkers, Tumor/blood , Middle Aged , Female , Chromatography, Liquid/methods , Liver Cirrhosis/blood , Liver Cirrhosis/diagnosis , Principal Component Analysis , Aged , Mass Spectrometry/methods , Adult , Case-Control Studies
SELECTION OF CITATIONS
SEARCH DETAIL